Ítem
Solo Metadatos
Chronic intrathecal baclofen administration in severe spasticity
Título de la revista
Autores
Broseta, J.
Garcia-March, G.
Sánchez-Ledesma, M.J.
Anaya, Juan-Manuel
Silva, I.
Fecha
1990-11-28
Directores
ISSN de la revista
Título del volumen
Editor
Karger AG
Buscar en:
Métricas alternativas
Resumen
Abstract
On the basis of previous experimental and clinical studies, 14 patients with severe spasticity due to central or spinal cord damage, resistant to all conservative treatments, were selected after a percutaneous trial period for chronic intrathecal baclofen infusion by programmable pumps. The agent was delivered at C4 in quadriplegic patients or in cases with central spasticity and in the neighbouring areas on the affected segments in paraplegic patients. The daily baclofen dose varied from 25 to 260 µg and was infused in a bolus, continuously infused or both combined according to the results during the trial period. After a mean follow-up period of 11 months, constant decrease of rigidity, absence of spasms, improvement of bladder function, cramping pain remission, and moderate improvement in walking capacity and transfer activities were usually observed. Neither complications nor side effects were noted.
Palabras clave
Keywords
Baclofen , Spasticity , Programmable pumps , Spinal infusion
